Monitoring
Cryptococcal meningitis
Patients who have recovered from cryptococcal meningitis require careful follow-up for recurrence of symptoms.
Patients who are already diagnosed with HIV should continue their antiretroviral therapy. In treatment-naive HIV-infected patients with a recent diagnosis of cryptococcal meningitis, delaying antiretroviral therapy for 5 weeks was associated with improved survival compared with therapy initiation at 1 to 2 weeks, especially among patients with a paucity of white cells in cerebrospinal fluid (CSF).[106]
Treatment of cryptococcal meningitis in HIV-infected patients is complicated by the development of immune reconstitution inflammatory syndrome in nearly 1 in 8 patients.[19]
Histoplasmal meningitis[27]
CSF analysis should be repeated after 1 month, when liposomal amphotericin-B is replaced by an azole antifungal, and at 1 year, and if failure or relapse is suspected.
Therapy should be continued until CSF abnormalities have resolved and CSF antigen (and serum and urine antigen if initially positive) is negative.[72]
Serum and urine antigen, if initially positive, can be repeated at 2 weeks, 1 month, and then 3-monthly during therapy and for at least 6 months after treatment is terminated.
Patients in whom treatment failure or relapse is suspected should also have antigen levels measured.
Coccidioidal meningitis[11]
CSF analysis is repeated monthly initially.
If response is satisfactory, CSF is repeated 3-monthly for life.
Serum and CSF complement fixing-type antibodies decrease with successful therapy.
Candidal meningitis[75]
Due to the high rates of relapse in candidal meningitis, antifungal therapy must be given for a minimum of 4 weeks after resolution of all signs and symptoms.
All CSF analysis and radiologic findings should also normalize prior to stopping antifungal therapy.
Use of this content is subject to our disclaimer